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Background
Repaired tetralogy of Fallot (rtoF) patients are at risk ventricular tachyarrhythmia and sudden cardiac death. Risk stratification for arrhythmia remains difficult.
We aimed to investigate whether cardiac anatomy and function assessed by cardiac magnetic resonance imaging (CMR) predict arrhythmia.
Methods
One-hundred-and-fifty-four adults with rtoF, median age 30.8 (21.9-40.2) years, were studied with a standardised protocol including cardiovascular magnetic resonance (CMR) and prospectively followed-up over median 5.6 (4.6-7.0) years for the pre-specified endpoints of newonset ventricular tachyarrhythmia (sustained ventricular tachycardia/ventricular fibrillation).
Results
Nine patients had ventricular tachyarrhythmia (6%) during follow-up. Patients who developed ventricular tachyarrhythmia were older (42.5 [34.9-50.2] vs. 29 [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] Interval 1.01-1.08 per mm; p=0.004). The survival ROC curve analysis indicated a cut-off value of 30mm as a predictor of VA during 6 year follow-up with an AUC of 0.77, sensitivity of 83% and specificity of 61%. RVOT akinetic area length >30mm predicted reduced VA-free survival (Logrank p=0.002).
Conclusions
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